Placebo responses in ankylosing spondylitis patients worldwide: variations and possible explanations.

Wei, James Cheng-Chung; Zhang, Li-Jun; Huang, Jin-Xian

Wei, James Cheng-Chung; Zhang, Li-Jun; Huang, Jin-Xian.

Afiliação

Wei JC; Department of Rheumatology, BenQ Medical Center, the Affiliated BenQ Hospital of Nanjing Medical University , China.
Zhang LJ; Division of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Institute of Medicine, Chung Shan Medical University; Graduate Institute of Integrated Medicine, China Medical University , Taichung, Taiwan.
Huang JX; Division of Rheumatology, Department of Medicine, The University of Hong Kong-Shenzhen Hospital , Shenzhen, China.

Expert Rev Clin Immunol ; 16(5): 447-450, 2020 05.

Article em En | MEDLINE | ID: mdl-32213079

Assuntos

Antirreumáticos/uso terapêutico; Espondilite Anquilosante/tratamento farmacológico; Humanos; Efeito Placebo; Resultado do Tratamento

Palavras-chave

ASAS20; ASAS40; Placebo; ankylosing spondylitis; non-radiographic axial spondyloarthritis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espondilite Anquilosante / Antirreumáticos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Expert Rev Clin Immunol Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google